Literature DB >> 23812803

The exon 3 polymorphism of the growth hormone receptor is a severity-related factor for osteoporosis.

Felipe Albuquerque Marques1, Túlio Cesar Lins, Ricardo Moreno Lima, Rômulo Maia Carlos Fonseca, Nanci Maria de França, Ricardo Jacó de Oliveira, Maria Teresinha de Oliveira Cardoso, Rinaldo Wellerson Pereira, Robert Pogue.   

Abstract

The purpose of this study was to investigate the association between the GHR exon 3 fl/d3 polymorphism and body composition traits in Brazilian cohorts of normal post-menarche adolescent girls and in post-menopausal women with and without osteoporosis. First, multiplex PCR and quantitative PCR (TaqMan) were used with 105 DNA samples from the general Brazilian population to validate the SNP rs6873545 as a surrogate marker for the GHR polymorphism. Subsequently, genotyping was carried out to evaluate associations for this polymorphism in 136 post-menarche adolescents and 175 post-menopausal women, who were evaluated for body composition traits such as bone mineral density and fat-free mass. Statistical analysis used an independent sample t test, one-way ANOVA test and post hoc Tukey HSD test. Significant values were assumed by p < 0.05. Genotyping indicated complete linkage disequilibrium between the GHR polymorphism and the SNP alleles (r(2) = 1.0). Adolescents and healthy post-menopausal women showed no genotype associations for body composition traits or osteoporosis. However, a lower total body bone mineral density was observed in fl/fl post-menopausal women with osteoporosis (p = 0.0004). These results suggest that the SNP rs6873545 can be used as a surrogate for the GHR fl/d3 polymorphism due to linkage disequilibrium in the Brazilian population and that the fl/fl genotype is a severity-related risk factor for osteoporosis, but did not appear to be associated with disease status.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23812803     DOI: 10.1007/s12020-013-0004-1

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  55 in total

Review 1.  Human population structure and genetic association studies.

Authors:  Elad Ziv; Esteban González Burchard
Journal:  Pharmacogenomics       Date:  2003-07       Impact factor: 2.533

2.  The fate of circulating osteoblasts.

Authors:  Ernesto Canalis
Journal:  N Engl J Med       Date:  2005-05-12       Impact factor: 91.245

3.  The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.

Authors:  G Binder; F Baur; R Schweizer; M B Ranke
Journal:  J Clin Endocrinol Metab       Date:  2005-11-15       Impact factor: 5.958

4.  Suggestive linkage to chromosome 1q for bone mineral apparent density in Brazilian sister adolescents.

Authors:  Romulo Maia Carlos Fonseca; Nanci Maria de França; Rinaldo Wellerson Pereira
Journal:  Joint Bone Spine       Date:  2011-07-02       Impact factor: 4.929

Review 5.  The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

Authors:  L C Hofbauer; S Khosla; C R Dunstan; D L Lacey; W J Boyle; B L Riggs
Journal:  J Bone Miner Res       Date:  2000-01       Impact factor: 6.741

6.  Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth.

Authors:  F Lupu; J D Terwilliger; K Lee; G V Segre; A Efstratiadis
Journal:  Dev Biol       Date:  2001-01-01       Impact factor: 3.582

Review 7.  Influence of growth hormone on accretion of bone mass.

Authors:  J P Monson; W M Drake; P V Carroll; J U Weaver; J Rodriguez-Arnao; M O Savage
Journal:  Horm Res       Date:  2002

8.  Influence of the exon 3-deleted/full-length growth hormone (GH) receptor polymorphism on the response to GH replacement therapy in adults with severe GH deficiency.

Authors:  Edna J L Barbosa; Jenny Palming; Camilla A M Glad; Helena Filipsson; Josef Koranyi; Bengt-Ake Bengtsson; Lena M S Carlsson; Cesar L Boguszewski; Gudmundur Johannsson
Journal:  J Clin Endocrinol Metab       Date:  2008-12-02       Impact factor: 5.958

9.  Clinical and biochemical impact of the d3 growth hormone receptor genotype in acromegaly.

Authors:  Moisés Mercado; Baldomero González; Carolina Sandoval; Yoshua Esquenazi; Fernando Mier; Guadalupe Vargas; Ana Laura Espinosa de los Monteros; Ernesto Sosa
Journal:  J Clin Endocrinol Metab       Date:  2008-07-08       Impact factor: 5.958

10.  Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism.

Authors:  Yong Fan; Ram K Menon; Pinchas Cohen; David Hwang; Thomas Clemens; Douglas J DiGirolamo; John J Kopchick; Derek Le Roith; Massimo Trucco; Mark A Sperling
Journal:  J Biol Chem       Date:  2009-05-21       Impact factor: 5.157

View more
  2 in total

1.  Rapid method for growth hormone receptor exon 3 delete (GHRd3) SNP genotyping from archival human placental samples.

Authors:  Rebecca A Pelekanos; Varda S Sardesai; Marloes Dekker Nitert; Leonie K Callaway; Nicholas M Fisk; Penny L Jeffery
Journal:  Endocrine       Date:  2015-06-12       Impact factor: 3.633

2.  A descriptive study on selected growth parameters and growth hormone receptor gene in healthy young adults from the American Midwest.

Authors:  Samantha N Hartin; Waheeda A Hossain; Ann M Manzardo; Shaquanna Brown; Paula J Fite; Marco Bortolato; Merlin G Butler
Journal:  Growth Horm IGF Res       Date:  2018-02-12       Impact factor: 2.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.